Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Bicycle Therapeutics

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2009 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$73M
Latest reported FY

Investors

16 investors on Bicycle Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Novartis Venture Fund
Series A 4 investors entered at this stage
Astellas Venture
SV Health Investors
Atlas Venture
SR One
Series B+ 11 investors entered at this stage
University of Cambridge
EPFL Swiss Federal Polytechnic School of Lausanne
RA Capital Management
Longwood Fund
Cambridge Innovation Capital
Forbion Capital Partners
Fairmount Funds Management
Vertex Ventures HC
Deep Track Capital
EcoR1 Capital
Perceptive Advisors

Global footprint

Where Bicycle Therapeutics has talent and traffic

AI talent share
2.8% of workforce is AI talent
(8 of 282 staff)
Core AI20.71%
Other AI62.13%
Non-AI workforce27497.16%
Web traffic by country
10K monthly visits
across markets
🇺🇸 United States46%
🇬🇧 United Kingdom36%
🇯🇵 Japan14%
🇮🇳 India6%
🇫🇷 France1%
Top 5 markets shown

Patent intelligence

$38M patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$38M
20.3× smaller than top peer BioNTech ($780M)
8 active patent families
Where Bicycle Therapeutics innovates Molecular biologyPeptide ligandCarcinosisKallikreinPeptide
Above peer median on Legal, Market

Quality vs same-sector peers

Bicycle Therapeutics on the five Patsnap quality dimensions

Bicycle Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Bicycle Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Bicycle Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Bicycle Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo